Substance Use Disorders Leadership ECHO

Fourth Monday of each month, noon - 1 p.m.


Leaders across Oregon SUD agencies are invited to participate in the Substance Use Disorders Leadership ECHO.

This ECHO is designed to:

Share emerging resources, best practices, and policy updates
Support partnerships across interdisciplinary and regional agencies
Provide a learning community and idea incubator

Leaders from Oregon healthcare, addiction, and recovery community SUD agencies are encouraged to register. 

The Oregon SUD Leadership ECHO is committed to including a diverse range of voices and perspectives. We hope to include and prioritize a diverse and inclusive group of leaders and organizations to best meet the needs of all Oregonians and improve health equity. Because of limited space, we ask that only one or two people per organization register and then disseminate key information throughout their organizations.

CME Information:

Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit: OHSU School of Medicine designates this live activity for a maximum 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with their participation in this activity

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, SUD Leadership ECHO has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

  • Family Medicine
  • Psychiatry and Neurology

This program is registered for MOC through the American Board of Internal Medicine (ABIM)


In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education, each instructor and member of the planning committee has been asked to disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). The information disclosed for this activity is listed below.


Honora Englander, M.D., F.A.C.P.:  Nothing to Disclose

Jessica Gregg, M.D., Ph.D.: Nothing to Disclose


Honora Englander, M.D., F.A.C.P.:  Nothing to Disclose

Jessica Gregg, M.D., Ph.D.: Nothing to Disclose

Melissa Lewis, Ph.D.: Nothing to Disclose

Tara Herivel, J.D.: Nothing to Disclose

Haven Wheelock: Nothing to Disclose

Stacie Andoniadis: Nothing to Disclose



Session/Title Date
0 - Session 0 8/23/2020
1 - Decolonizing Addiction 8/24/2020
2 - SUD Care for Incarcerated People 9/28/2020
3 - Prime + 10/26/2020
4 - Drug Decriminalization and Addiction Treatment Initiative 11/16/2020
5 - Harm Reduction Med-Ed 1/25/2021
6 - Clinician Wellness 2/22/2021
7 - Contingency Management in SUD Settings 3/22/2021
8 - Nalox Box 4/26/2021
9 - SUD System Change 5/24/2021
10 - Session 10 6/28/2021
11 - Session 11 7/26/2021
Sign Up For This ECHO